4-(4-Aminophenoxy)-N-methylpicolinamide

Catalog No.: 
ACOKMY134
CAS No.: 
284462-37-9
Molecular Formula: 
C13H13N3O2
Molecular Weight: 
243.27
4-(4-Aminophenoxy)-N-methylpicolinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$69.00In stockInquiry
500g97%$276.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Aminophenoxy)-N-methylpicolinamide
IUPAC Name4-(4-aminophenoxy)-N-methylpicolinamide
MDL No.MFCD08692047
Molecular FormulaC13H13N3O2
Molecular Weight243.27
SMILESNC2=CC=C(OC1=CC=NC(=C1)C(=O)NC)C=C2
InChI KeyRXZZBPYPZLAEFC-UHFFFAOYSA-N
Synonym4-(4-Aminophenoxy)-N-methylpicolinamide | FT-0661989 | 4-(4-Aminophenoxy)-N-methylpyridine-2-carboxamide | 4-(2-(N-methylcarbarnoyl)-4-pyridyloxy)aniline | AM20061802 | AKOS005174935 | EN300-146904 | RXZZBPYPZLAEFC-UHFFFAOYSA-N | SCHEMBL235245 | UNII-RE33
CAS No.284462-37-9
PubChem CID16655129

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOKMY134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIAGD894 route compound structure diagram
    ACIAGD894220000-87-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOKMY134 route product structure diagram
    ACOKMY134284462-37-9In Stock
Inquiry

2. ACOKMY134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOKMY134 route product structure diagram
    ACOKMY134284462-37-9In Stock
Inquiry

3. ACOKMY134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOKMY134 route product structure diagram
    ACOKMY134284462-37-9In Stock
Inquiry

Comments (0)